Uterine/Endometrial Cancer

Sponsored diagnostic testing programs for Uterine/Endometrial Cancer

Inherited variants associated with Lynch syndrome (MLH1, MSH2, MSH6, PMS2, EPCAM) and PTEN hamartoma tumor syndrome increase the risk of uterine or endometrial cancer. Genetic testing helps clarify risk and guide surveillance.

1 program found for Uterine/Endometrial Cancer

Programs

1 program

Ovarian Cancer

Sponsored by
Ovarian Cancer Research Alliance
AstraZeneca
GSK
Merck
Genentech

Color Hereditary Cancer Test

This program provides no-charge hereditary cancer testing for patients at increased risk for ovarian or gynecologic cancers, as well as other related hereditary cancer syndromes. Eligible patients receive an at-home saliva collection kit processed by Color Health. Results include access to certified genetic counselors, supporting clinical decision-making and risk assessment.

Oncology